HeartWare to float new shares
Thursday, 05 June, 2008
HeartWare (ASX: HTW) will hold an extraordinary general meeting next month to receive shareholder permission to float up to 70 million new shares.
The shares will be offered privately to professional investors in Australia and the US, and will be sold at $0.50 cents a share.
The purpose of the listing is to raise $30 million in capital. HeartWare, which manufactures miniature medical devices, will offer a share purchase plan to allow current stockholders the opportunity to purchase the new shares at the same price as that offered to the private investors.
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
Australia's first cases of H5 avian influenza confirmed
Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...
